Asia Pacific Key To Speeding Up Drug Development, Says Quintiles' Tharmaratnam

This article was originally published in The Pink Sheet Daily

11 Jun 2010
News

The Pink Sheet Daily pinkeditor@informa.com

Executive Summary

In an interview, Quintiles Asia Pacific Head of Clinical Development Anand Tharmaratnam says that helping to facilitate the globalization of clinical trials is one of Asia's main contributions in advancing the pharmaceutical industry.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Regions
Asia Pacific

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Asia Pacific

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS070743

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS070743

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Asia Pacific Key To Speeding Up Drug Development, Says Quintiles' Tharmaratnam

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert